
Leading experts explore how AI is reshaping CNS drug development, from trial design and data interpretation to patient enrichment and real-world outcomes. Featuring discussions with Gary Sachs, Luca Pani, and Amir Kalali mindthemethods.buzzsprout.com

English


















